机译:胃癌同步肝转移的多学科治疗后稳定疾病的长期生存:一例报告
CEA; carcino-embryonic antigen; CA 199; carbohydrate antigen 199; CA 724; carbohydrate antigen 724; CT; computed tomography; EBV; Epstein-Barr virus; ECOG PS; Eastern Cooperative Oncology Group performance status; FISH; fluorescence in situ hybridization; GCLM; gastric cancer with liver metastases; HER-2; human epidermal growth factor receptor-2; KPS; Karnofsky; L-ADM; liposome-entrapped Adriamycin; MDT; multidisciplinary team; MSI-H; microsatellite instability-high; NCCN; the National Comprehensive Cancer Network; PVC; portal vein chemotherapy; PEI; percutaneous ethanol injection; PD-L1; programmed death-ligand 1; PFS; progression free survival; TACE; transcatheter hepatic artery chemoembolization; RFA; radiofrequency ablation; RECIST; response evaluation criteria in solid tumors; S-1; tegafur; SD; stable disease; WHO; World Health Organization;
机译:多学科治疗胃癌同步肝转移后的长期存活与胃癌的同步肝转移率为:案例报告
机译:胃腺癌胃癌和肝异位手术及多发性,同步肝转移术后长期无复发生存:一例并文献复习
机译:胃癌同步肝转移患者胃,肝手术治疗后生存改善的预测因素
机译:胃癌肝脏转移的手术治疗
机译:在基于社区的血液学/肿瘤学实践中,国家报告的乳腺癌生存统计数据与乳腺癌生存率之间的比较
机译:胃腺癌胃癌和肝脏异位手术及多发性同步肝转移术后长期无复发生存:一例并文献复习
机译:胃腺癌的胃和肝脏中等胃癌和多重,同步肝转转移后的长期复发存活:案例报告和文学审查